Bruno Marchand Selected Research

Bruno Marchand Research Topics

2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 10/2020
2	Fibrosis (Cirrhosis) 01/2022 - 10/2020
2	Infections 01/2009 - 11/2002
1	Hypertriglyceridemia 01/2022
1	Inflammation (Inflammations) 10/2020
1	Alcoholic Fatty Liver 10/2020
1	Liver Diseases (Liver Disease) 10/2020
1	HIV Infections (HIV Infection) 12/2009
1	Drug-Related Side Effects and Adverse Reactions 01/2009
1	Neoplasms (Cancer) 12/2002
1	Neoplasm Metastasis (Metastasis) 11/2002
1	Pathologic Constriction (Stenosis) 06/2002

2	LipidsIBA 01/2022 - 10/2020
2	Choline (Choline Chloride)IBA 01/2022 - 10/2020
2	NucleosidesIBA 12/2009 - 01/2009
1	Thyroid Hormone Receptors beta (TR beta)IBA 01/2022
1	Acetyl-CoA CarboxylaseIBA 01/2022
1	Fenofibrate (CiL)FDA LinkGeneric 01/2022
1	lanifibranorIBA 01/2022
1	firsocostatIBA 01/2022
1	saroglitazarIBA 01/2022
1	seladelparIBA 01/2022
1	2- (2,6- dimethyl- 4- (3- (4- (methylthio)phenyl)- 3- oxo- 1- propenyl)phenoxyl)- 2- methylpropanoic acidIBA 01/2022
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2022
1	resmetiromIBA 01/2022
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 10/2020
1	ProcollagenIBA 10/2020
1	Reverse Transcriptase InhibitorsIBA 12/2009
1	Ribonuclease H (RNase H)IBA 01/2009
1	Anti-HIV Agents (AIDS Drugs)IBA 01/2009
1	Glucose (Dextrose)FDA LinkGeneric 12/2002
1	Contrast MediaIBA 06/2002
1	gadolinium 1,4,7,10- tetraazacyclododecane- N,N',N'',N'''- tetraacetateIBA 06/2002

2	Therapeutics 01/2022 - 12/2009
1	Radiofrequency Ablation 11/2002